Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice

Abstract Background Vitamin D is an essential nutrient in musculoskeletal function; however, its relationship to sarcopenia remains ambiguous, and the mechanisms and targets of vitamin D activity have not been elucidated. This study aimed to clarify the role of vitamin D in mature skeletal muscle an...

Full description

Bibliographic Details
Main Authors: Takafumi Mizuno, Tohru Hosoyama, Makiko Tomida, Yoko Yamamoto, Yuko Nakamichi, Shigeaki Kato, Minako Kawai‐Takaishi, Shinya Ishizuka, Yukiko Nishita, Chikako Tange, Hiroshi Shimokata, Shiro Imagama, Rei Otsuka
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Online Access:https://doi.org/10.1002/jcsm.13102
_version_ 1827280048064823296
author Takafumi Mizuno
Tohru Hosoyama
Makiko Tomida
Yoko Yamamoto
Yuko Nakamichi
Shigeaki Kato
Minako Kawai‐Takaishi
Shinya Ishizuka
Yukiko Nishita
Chikako Tange
Hiroshi Shimokata
Shiro Imagama
Rei Otsuka
author_facet Takafumi Mizuno
Tohru Hosoyama
Makiko Tomida
Yoko Yamamoto
Yuko Nakamichi
Shigeaki Kato
Minako Kawai‐Takaishi
Shinya Ishizuka
Yukiko Nishita
Chikako Tange
Hiroshi Shimokata
Shiro Imagama
Rei Otsuka
author_sort Takafumi Mizuno
collection DOAJ
description Abstract Background Vitamin D is an essential nutrient in musculoskeletal function; however, its relationship to sarcopenia remains ambiguous, and the mechanisms and targets of vitamin D activity have not been elucidated. This study aimed to clarify the role of vitamin D in mature skeletal muscle and its relationship with sarcopenia. Methods This epidemiological study included 1653 community residents who participated in both the fifth and seventh waves of the National Institute for Longevity Sciences, Longitudinal Study of Aging and had complete background data. Participants were classified into two groups: vitamin D‐deficient (serum 25‐hydroxyvitamin D < 20 ng/mL) and non‐deficient (serum 25‐hydroxyvitamin D ≥ 20 ng/mL); they underwent propensity‐score matching for background factors (age, sex, height, weight, comorbidities, smoker, alcohol intake, energy intake, vitamin D intake, steps, activity, season and sarcopenia). Changes in muscle strength and mass over the 4‐year period were compared. For basic analysis, we generated Myf6CreERT2 Vitamin D Receptor (VDR)‐floxed (VdrmcKO) mice with mature muscle fibre‐specific vitamin D receptor knockout, injected tamoxifen into 8‐week‐old mice and analysed various phenotypes at 16 weeks of age. Results Grip strength reduction was significantly greater in the deficient group (−1.55 ± 2.47 kg) than in the non‐deficient group (−1.13 ± 2.47 kg; P = 0.019). Appendicular skeletal muscle mass reduction did not differ significantly between deficient (−0.05 ± 0.79 kg) and non‐deficient (−0.01 ± 0.74 kg) groups (P = 0.423). The incidence of new cases of sarcopenia was significantly higher in the deficient group (15 vs. 5 cases; P = 0.039). Skeletal muscle phenotyping of VdrmcKO mice showed no significant differences in muscle weight, myofibre percentage or myofibre cross‐sectional area; however, both forelimb and four‐limb muscle strength were significantly lower in VdrmcKO mice (males: forelimb, P = 0.048; four‐limb, P = 0.029; females: forelimb, P < 0.001; four‐limb, P < 0.001). Expression profiling revealed a significant decrease in expression of sarcoendoplasmic reticulum Ca2+‐ATPase (SERCA) 1 (P = 0.019) and SERCA2a (P = 0.049) genes in the VdrmcKO mice. In contrast, expression of non‐muscle SERCA2b and myoregulin genes showed no changes. Conclusions Vitamin D deficiency affects muscle strength and may contribute to the onset of sarcopenia. Vitamin D‐VDR signalling has minimal influence on the regulation of muscle mass in mature myofibres but has a significant influence on muscle strength.
first_indexed 2024-04-11T13:59:26Z
format Article
id doaj.art-8e9f5c22af434f948b14efc99c5885e0
institution Directory Open Access Journal
issn 2190-5991
2190-6009
language English
last_indexed 2024-04-24T08:30:16Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Journal of Cachexia, Sarcopenia and Muscle
spelling doaj.art-8e9f5c22af434f948b14efc99c5885e02024-04-16T20:10:20ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092022-12-011362961297310.1002/jcsm.13102Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout miceTakafumi Mizuno0Tohru Hosoyama1Makiko Tomida2Yoko Yamamoto3Yuko Nakamichi4Shigeaki Kato5Minako Kawai‐Takaishi6Shinya Ishizuka7Yukiko Nishita8Chikako Tange9Hiroshi Shimokata10Shiro Imagama11Rei Otsuka12Department of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Musculoskeletal Disease Geroscience Research Center, National Center for Geriatrics and Gerontology Obu JapanDepartment of Epidemiology of Aging National Center for Geriatrics and Gerontology Obu JapanDepartment of Surgical Oncology The University of Tokyo Tokyo JapanInstitute for Oral Science Matsumoto Dental University Nagano JapanGraduate School of Life Science and Engineering Iryo Sosei University Fukushima JapanDepartment of Musculoskeletal Disease Geroscience Research Center, National Center for Geriatrics and Gerontology Obu JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Epidemiology of Aging National Center for Geriatrics and Gerontology Obu JapanDepartment of Epidemiology of Aging National Center for Geriatrics and Gerontology Obu JapanDepartment of Epidemiology of Aging National Center for Geriatrics and Gerontology Obu JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Epidemiology of Aging National Center for Geriatrics and Gerontology Obu JapanAbstract Background Vitamin D is an essential nutrient in musculoskeletal function; however, its relationship to sarcopenia remains ambiguous, and the mechanisms and targets of vitamin D activity have not been elucidated. This study aimed to clarify the role of vitamin D in mature skeletal muscle and its relationship with sarcopenia. Methods This epidemiological study included 1653 community residents who participated in both the fifth and seventh waves of the National Institute for Longevity Sciences, Longitudinal Study of Aging and had complete background data. Participants were classified into two groups: vitamin D‐deficient (serum 25‐hydroxyvitamin D < 20 ng/mL) and non‐deficient (serum 25‐hydroxyvitamin D ≥ 20 ng/mL); they underwent propensity‐score matching for background factors (age, sex, height, weight, comorbidities, smoker, alcohol intake, energy intake, vitamin D intake, steps, activity, season and sarcopenia). Changes in muscle strength and mass over the 4‐year period were compared. For basic analysis, we generated Myf6CreERT2 Vitamin D Receptor (VDR)‐floxed (VdrmcKO) mice with mature muscle fibre‐specific vitamin D receptor knockout, injected tamoxifen into 8‐week‐old mice and analysed various phenotypes at 16 weeks of age. Results Grip strength reduction was significantly greater in the deficient group (−1.55 ± 2.47 kg) than in the non‐deficient group (−1.13 ± 2.47 kg; P = 0.019). Appendicular skeletal muscle mass reduction did not differ significantly between deficient (−0.05 ± 0.79 kg) and non‐deficient (−0.01 ± 0.74 kg) groups (P = 0.423). The incidence of new cases of sarcopenia was significantly higher in the deficient group (15 vs. 5 cases; P = 0.039). Skeletal muscle phenotyping of VdrmcKO mice showed no significant differences in muscle weight, myofibre percentage or myofibre cross‐sectional area; however, both forelimb and four‐limb muscle strength were significantly lower in VdrmcKO mice (males: forelimb, P = 0.048; four‐limb, P = 0.029; females: forelimb, P < 0.001; four‐limb, P < 0.001). Expression profiling revealed a significant decrease in expression of sarcoendoplasmic reticulum Ca2+‐ATPase (SERCA) 1 (P = 0.019) and SERCA2a (P = 0.049) genes in the VdrmcKO mice. In contrast, expression of non‐muscle SERCA2b and myoregulin genes showed no changes. Conclusions Vitamin D deficiency affects muscle strength and may contribute to the onset of sarcopenia. Vitamin D‐VDR signalling has minimal influence on the regulation of muscle mass in mature myofibres but has a significant influence on muscle strength.https://doi.org/10.1002/jcsm.13102Vitamin D deficiencySarcopeniaMuscle strengthMuscle mass
spellingShingle Takafumi Mizuno
Tohru Hosoyama
Makiko Tomida
Yoko Yamamoto
Yuko Nakamichi
Shigeaki Kato
Minako Kawai‐Takaishi
Shinya Ishizuka
Yukiko Nishita
Chikako Tange
Hiroshi Shimokata
Shiro Imagama
Rei Otsuka
Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
Journal of Cachexia, Sarcopenia and Muscle
Vitamin D deficiency
Sarcopenia
Muscle strength
Muscle mass
title Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
title_full Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
title_fullStr Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
title_full_unstemmed Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
title_short Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice
title_sort influence of vitamin d on sarcopenia pathophysiology a longitudinal study in humans and basic research in knockout mice
topic Vitamin D deficiency
Sarcopenia
Muscle strength
Muscle mass
url https://doi.org/10.1002/jcsm.13102
work_keys_str_mv AT takafumimizuno influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT tohruhosoyama influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT makikotomida influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT yokoyamamoto influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT yukonakamichi influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT shigeakikato influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT minakokawaitakaishi influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT shinyaishizuka influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT yukikonishita influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT chikakotange influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT hiroshishimokata influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT shiroimagama influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice
AT reiotsuka influenceofvitamindonsarcopeniapathophysiologyalongitudinalstudyinhumansandbasicresearchinknockoutmice